LLY · News · 20261102N

Revenue Performance and Mix

ELI LILLY & Co · 2026-11-02 · Importance 75 · Surprise 64

Eli Lilly reported quarterly revenue of $24.397 billion on October 29, with Mounjaro contributing $10.723 billion and Zepbound $5.352 billion. Together, the two medicines generated 65.9% of quarterly revenue, concentrating sales in the metabolic franchise. Worldwide volume rose 53%, while realized prices fell 15%. Full-year revenue guidance was $91 billion to $92 billion.

Key facts

• Eli Lilly's Mounjaro generated $10.723 billion in quarterly revenue. source
• Eli Lilly's Zepbound generated $5.352 billion in quarterly revenue. source
• Mounjaro and Zepbound together supplied 65.9% of Eli Lilly's revenue. source
• Eli Lilly's worldwide volume rose 53%, while realized prices fell 15%. source